New nasal vaccine aims to protect little lungs from RSV
⭐️ VACCINE ⭐️
Recruiting now
This study tests a new nasal spray vaccine (BLB-201) to see if it is safe and helps the body fight RSV, a common virus that can cause serious breathing problems in babies and young children. About 137 infants and children aged 8 to 59 months, some who have had RSV before and some…
Phase: PHASE1, PHASE2 • Sponsor: Blue Lake Biotechnology Inc. • Aim: ⭐️ VACCINE ⭐️
Last updated Apr 30, 2026 15:49 UTC